TY - JOUR T1 - The impact of anorexia nervosa and obesity polygenic risk on childhood growth: a 20-year longitudinal population-based study JF - medRxiv DO - 10.1101/2020.10.15.20200600 SP - 2020.10.15.20200600 AU - Mohamed Abdulkadir AU - Christopher Hübel AU - Moritz Herle AU - Ruth J.F. Loos AU - Gerome Breen AU - Cynthia M. Bulik AU - Nadia Micali Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/16/2020.10.15.20200600.abstract N2 - Background Deviating growth from the norm during childhood has been associated with anorexia nervosa (AN) and obesity later in life. In this study, we examined whether polygenic scores (PGS) for AN and obesity are associated, individually or combined, with a range of anthropometric trajectories spanning the first two decades of life.Methods AN-PGS and obesity-PGS were calculated for participants of the Avon Longitudinal Study of Parents and Children (ALSPAC; N= 8,654 participants with genotype data and at least one outcome measure). Using generalized (mixed) linear models, we associated PGS with trajectories of weight, height, body mass index (BMI), fat mass index (FMI), lean mass index (LMI), and bone mineral density (BMD). Growth trajectories were derived using spline modeling or mixed effects modeling.Results Between age 5-24 years, Females with one SD higher AN-PGS had on average a 0.01% lower BMI trajectory, and between age 10-24 years a 0.01% lower FMI trajectory and 0.05% lower weight trajectory. Higher obesity-PGS was associated with higher BMI, FMI, LMI, BMD, weight, and lower height trajectories in both sexes. The average growth trajectories of females with high AN-PGS/low obesity-PGS remained consistently lower than those with low AN-PGS/low obesity-PGS; this difference did not reach statistical significance. However, post-hoc comparisons suggest that females with high AN-PGS/low obesity-PGS did follow lower growth trajectories compared to those with high PGS for both traits.Conclusion AN-PGS and obesity-PGS have detectable sex-dependent effects on a range of anthropometry trajectories. These findings encourage further research in understanding how the AN-PGS and the obesity-PGS co-influence growth during childhood in which the obesity-PGS can mitigate the effects of the AN-PGS.Competing Interest StatementDr. Breen has received grant funding from and served as a consultant to Eli Lilly, has received honoraria from Illumina and has served on advisory boards for Otsuka. Dr. Bulik is a grant recipient from and has served on advisory boards for Shire and is a consultant for Idorsia. She receives royalties from Pearson. All other authors have indicated they have no conflicts of interest to disclose.Clinical TrialALSPAC is a longitudinal birth cohort and as such is not a clinical trial. The study has been approved by the Research Ethics Committee. The initial approvals of the study were: 1. Bristol and Weston Health Authority: E1808 Children of the Nineties: Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). (28th November 1989) 2. Southmead Health Authority: 49/89 Children of the Nineties - "ALSPAC". (5th April 1990) 3. Frenchay Health Authority: 90/8 Children of the Nineties. (28th June 1990) For more details regarding ethical approval please visit: http://www.bristol.ac.uk/alspac/researchers/research-ethics/.Funding StatementThis study represents independent research part funded by the UK National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King College London. The views expressed are those of the author(s) and not necessarily those of the UK NHS, the NIHR or the Department of Health. High performance computing facilities were funded with capital equipment grants from the GSTT Charity (TR130505) and Maudsley Charity (980). This work was supported by the UK Medical Research Council and the Medical Research Foundation (ref: MR/R004803/1). The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2 and 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); This research was specifically funded by the NIHR (CS/01/2008/014), the NIH (MH087786-01). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. NM and CB acknowledge funding from the National Institute of Mental Health (R21 MH115397). CB acknowledges funding from the Swedish Research Council (VR Dnr: 538-2013-8864), the National Institute of Mental Health (R21MH115397; R01 MH109528; R01MH120170; R01MH119084). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders were not involved in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (Bristol and Weston Health Authority: E1808 Children of the Nineties: ALSPAC, 28th November 1989 (for details see: www.bristol.ac.uk/alspac/researchers/research-ethics/).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease note that the study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool" and reference the following webpage: http://www.bristol.ac.uk/alspac/researchers/our-data/.ALSPACAvon Longitudinal Study of Parents and ChildrenANAnorexia nervosaBMDBone mineral densityBMIBody mass indexcm2Centimeters squaredDEXADual emission X-ray absorptiometryEDEating disorderFMIFat mass indexGIANTGenetic investigation of anthropometric traitsGWASGenome-wide association studykgKilogramLMERLinear mixed effects regressionLMILean mass indexm2Meters squaredPGCPsychiatric genomics consortiumPGSPolygenic scoreREDCapResearch Electronic Data CapturergGenetic correlationSDStandard deviationSEStandard errorSNPSingle nucleotide polymorphismSTATAStatistics and data ER -